AIM ImmunoTech, Inc. (AIM)

1.19 -0.07 (-5.56%) USD  |  NYAM  |  Jan 23, 16:00
1.24 +0.05 (+4.20%) After-Hours: 20:00
More

AIM ImmunoTech Operating Income (5 Year Growth)

Operating Income (5 Year Growth) Chart

View Operating Income (5 Year Growth) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income Definition

View Operating Income Definition
Start Trial

Profit earned from a company's core business operations. It is gross profit less all operating expenses and depreciation.

Read full definition.

Operating Income (5 Year Growth) Range, Past 5 Years

View Operating Income (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (5 Year Growth) Benchmarks

View Operating Income (5 Year Growth) Benchmarks
Start Trial
Halozyme Therapeutics, Inc. --
Perspective Therapeutics, Inc. --
Protalix Biotherapeutics, Inc. --
Electromed, Inc. Upgrade
Armata Pharmaceuticals, Inc. --